Macroprolactinomas are benign prolactin-secreting pituitary tumors, causing amenorrhea, galactorrhea and gonadal dysfunction. Clinical treatment with dopamine agonists is the first-choice therapy. Surgery is indicated for the rare cases that are resistant to clinical treatment, when there is intolerance to the medication, or intratumoral hemorrhage is detected. We describe the case of a female patient with macroprolactinoma submitted to two surgical procedures and resistant to clinical treatment, with unusual evolution.
Reis RM, Ribeiro CT, Sá MFS, Carrara HHA, Machado HR, Santos AC. Macroprolactinoma resistant to dopamine agonists: a case report. Revista Brasileira de Ginecologia e Obstetrícia 2004;26(8):663-7.
Electronic Document Format (ABNT)
Reis, Rosana Maria dos; Ribeiro, Camila Toffoli; Sá, Marcos Felipe de Silva; Carrara, Hélio Humberto Angotti; Machado, Hélio Rubens; Santos, Antônio Carlos dos. Macroprolactinoma resistant to dopamine agonists: a case report. Revista Brasileira de Ginecologia e Obstetrícia, v. 26, n. 8, p. 663-667, Nov. 2004.
Electronic Document Format (APA)
Reis, R. M. , Ribeiro, C. T., Sá, M. F. S., Carrara, H. H. A., Machado, H. R., & Santos, A. C. (2004). Macroprolactinoma resistant to dopamine agonists: a case report. Revista Brasileira de Ginecologia e Obstetrícia, 26(8), 663-667.
Electronic Document Format (ISO)
Reis, Rosana Maria dos and Ribeiro, Camila Toffoli and Sá, Marcos Felipe de Silva and Carrara, Hélio Humberto Angotti and Machado, Hélio Rubens and Santos, Antônio Carlos dos. Macroprolactinoma resistant to dopamine agonists: a case report. Revista Brasileira de Ginecologia e Obstetrícia [online]. 2004, vol. 26, n. 8, [cited 2024-11-21], pp.663-667. Available from: <https://journalrbgo.org/article/macroprolactinoma-resistant-to-dopamine-agonists-a-case-report/>.
Comments